News

Colorado BioScience Association welcomes nationally recognized thought leaders to address state’s medical device industry

DENVER – Colorado BioScience Association (CBSA) highlights how changes in federal policy, major shifts in healthcare will impact the state’s thriving medical device industry as part of the annual CBSA Medical Device Symposium. Medical device sector policy discussions will cover the opportunities presented by proposed regulatory relief, corporate tax reform and the possible full repeal of the medical device excise tax under the new administration.

Additionally, speakers and panelists will discuss national healthcare trends, IP portfolio protections and the importance of partnering make up the agenda for the symposium, scheduled for Tuesday, January 24th at the Omni Interlocken Resort in Broomfield.

Highlights of the CBSA Medical Device Symposium, sponsored by Snell & Wilmer Law Offices, include:

  • Federal policy preview by Clayton Hall, Vice President of Government Affairs for the Medical Device Manufacturing Association
  • New national data and insights on the medtech sector from John Babitt, EY Medical Technology Leader for the Americas
  • Panel discussion: Protecting Your IP Portfolio
  • Panel discussion: Leveraging Partnerships for Success

April Giles, President & CEO of CBSA, says:

“CBSA is proud to bring nationally-recognized industry leaders to engage with Colorado companies and provide insights to support our sector’s success in a rapidly changing healthcare landscape.”

Supporting sponsors of the symposium include: Snell & Wilmer, EY, and Fitzsimons Redevelopment Authority.

The conference will be held from 1-5:30 p.m. at the Omni Interlocken Resort, 500 Interlocken Boulevard, in Broomfield. Registration is $50 for CBSA members and $100 for non-members.

Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn

About the Colorado BioScience Association
Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.

 

Media Contacts:

Tom Borak
Communications and Membership Manager
Colorado BioScience Association
(720) 382-5918
tborak@cobioscience.com

 

Sheliah Reynolds
Primavera Group for Colorado BioScience Association
(720) 289-4739
sheliah@theprimaveragroup.com



Go Back